Cases & Deals

Celgene files Hatch-Waxman suit against IntelliPharmaCeutics over Focalin XR® patent

Clients Celgene Corporation

Jones Day represented Celgene Corporation in a Hatch-Waxman patent litigation concerning a generic version of ADHD drug Focalin XR®.

Celgene Corporation, et al. v. IntelliPharmaCeutics Corp., Case No. 3-07-cv-04854 (D.N.J. 2007) (Judge Wolfson)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.